Literature DB >> 26461149

Pathogenesis of Hemophagocytic Lymphohistiocytosis.

Alexandra H Filipovich1, Shanmuganathan Chandrakasan2.   

Abstract

Hemophagocytic Lymphohistiocytosis (HLH), an inherited life-threatening inflammatory disorder, has gained growing recognition not only in children but also increasingly in adults over the past 2 decades. HLH involves inborn defects in lymphocytes, which normally mediate control of infectious and inflammatory conditions within the immune system and in other tissues. In the context of inherited defects in cytotoxic cells and other immune cells, the disorder is classified as familial or primary HLH. Secondary HLH occurs in the settings of infections or underlying rheumatologic disorders. Secondary HLH also accompanies some lymphoid malignancies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetics; Hemophagocytic lymphohistiocytosis; Pathogenesis; Pathophysiology; Secondary HLH; Treatment

Mesh:

Year:  2015        PMID: 26461149     DOI: 10.1016/j.hoc.2015.06.007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  21 in total

1.  Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections.

Authors:  Dana T Lounder; Qiong Bin; Cristina de Min; Michael B Jordan
Journal:  Blood Adv       Date:  2019-01-08

2.  Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-02-07

Review 3.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 4.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

5.  Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab.

Authors:  Grace Thompson; Dominic Pepperell; Ian Lawrence; Benjamin David McGettigan
Journal:  BMJ Case Rep       Date:  2017-02-22

6.  Secondary hemophagocytic lymphohistiocytosis: a case report.

Authors:  Lia Salvati; Anita Di Renzo; Sergio Moscardelli; Laura Natali; Ferri Claudio; Angelo Viscido
Journal:  Acta Biomed       Date:  2021-04-30

7.  Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.

Authors:  Lianna J Marks; Jennifer A Oberg; Danielle Pendrick; Anthony N Sireci; Chana Glasser; Carrie Coval; Rebecca J Zylber; Wendy K Chung; Jiuhong Pang; Andrew T Turk; Susan J Hsiao; Mahesh M Mansukhani; Julia L Glade Bender; Andrew L Kung; Maria Luisa Sulis
Journal:  Front Pediatr       Date:  2017-12-12       Impact factor: 3.418

8.  A Case of Spontaneously Improving Secondary Hemophagocytic Lymphohistiocytosis in an Adult Associated with T-Cell Histiocyte-Rich Large B-Cell Lymphoma.

Authors:  Cyrus Askin; Ashley Burris; Clifton Layman; Brian Haney; Jordan Hall
Journal:  Case Rep Oncol Med       Date:  2018-02-22

9.  An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.

Authors:  Aleksandra Gil-Krzewska; Mezida B Saeed; Anna Oszmiana; Elizabeth R Fischer; Kathryn Lagrue; William A Gahl; Wendy J Introne; John E Coligan; Daniel M Davis; Konrad Krzewski
Journal:  J Allergy Clin Immunol       Date:  2017-12-11       Impact factor: 10.793

10.  HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis.

Authors:  Rui Huang; Yoshihiro Hayashi; Xiaomei Yan; Jiachen Bu; Jieyu Wang; Yue Zhang; Yile Zhou; Yuting Tang; Lingyun Wu; Zefeng Xu; Xin Liu; Qianfei Wang; Jianfeng Zhou; Zhijian Xiao; James P Bridges; Rebecca A Marsh; Kejian Zhang; Michael B Jordan; Yuhua Li; Gang Huang
Journal:  Haematologica       Date:  2017-08-31       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.